Profile
Neil Nachshen
Partner / London
Practice & Professional Experience
Neil’s portfolio has evolved over his time at D Young & Co to be one that primarily concentrates on EPO oppositions and appeals, the provision of validity and infringement opinions, due diligence and litigation support, all in the field of pharmaceuticals. He still maintains expertise in advising small pharmaceutical companies in portfolio development and strategy, in particular in conjunction with due diligence for funding and stock market flotations.
Neil has been successful in many oppositions and appeals in the pharmaceutical area, mainly acting for Teva Pharmaceuticals on patents concerning the second medical use of approved drugs, formulations, polymorphs and synthetic processes. In many cases, these cases have been linked to litigation in EU member states. He has additionally advised other pharmaceutical clients completing IP due diligence for mergers, project acquisitions and flotation’s.
Neil’s background in biochemistry and pharmacology and his 20 years experience in patents, including time in-house at BTG and at Teva Pharmaceutical Industries Ltd in Israel, provide an ideal basis for this portfolio.
Neil features as a leading UK patent attorney in the ‘MIP Expert Guide to the Leading Patent Law Practitioners’ 2009.
Qualifications
BSc in Pharmacology, Kings College, University of London.
Certificate in Intellectual Property Law, Queen Mary College, University of London.
Patent Agent Litigator.
Chartered Patent Attorney 1996.
European Patent Attorney 1996.
European Design Attorney.
Memberships
Chartered Institute of Patent Attorneys (CIPA).
European Patent Institute (epi).
